Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

RxSight (RXST) Shares Outstanding (Weighted Average) (2020 - 2025)

RxSight's Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $40.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 5.1% year-over-year to $40.9 million; the TTM value through Dec 2025 reached $40.9 million, up 5.1%, while the annual FY2025 figure was $40.9 million, 5.1% up from the prior year.
  • Shares Outstanding (Weighted Average) reached $40.9 million in Q4 2025 per RXST's latest filing, roughly flat from $41.0 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $41.0 million in Q3 2025 to a low of $225945.0 in Q3 2022.
  • Average Shares Outstanding (Weighted Average) over 5 years is $28.1 million, with a median of $33.5 million recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): crashed 97.49% in 2022, then surged 14924.6% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $13.6 million in 2021, then soared by 103.02% to $27.7 million in 2022, then grew by 24.56% to $34.5 million in 2023, then grew by 12.81% to $38.9 million in 2024, then grew by 5.1% to $40.9 million in 2025.
  • Per Business Quant, the three most recent readings for RXST's Shares Outstanding (Weighted Average) are $40.9 million (Q4 2025), $41.0 million (Q3 2025), and $40.6 million (Q2 2025).